Investigation of anti-inflammatory drug usage in the treatment of epilepsy through analyzing the epilepsy-inflammation relation at the molecular level

Abstract

Epilepsy is a neurological brain disorder that affects social life by causing seizures, loss of consciousness, and muscle contractions. The causes of epilepsy include tumors, genetic diseases, brain injuries during childbirth, and infections affecting the body. Antiepileptic drugs are commonly used for treatment, but about one-third of individuals continue to experience seizures despite medication. These drugs effectively prevent seizures but do not address the underlying mechanisms of the disease. Inflammation, i.e. biological response of the body's immune system to harmful stimuli, can be the result or cause of various diseases and is recognized as one of the contributing factors to epilepsy. This study investigates the molecular-level connection between inflammation and epilepsy through mapping transcriptomic data to reconstructed protein-protein interaction (PPI) network, reveal important subnetworks and detect potential common drug targets for inflammation and epilepsy. The most connected hub proteins of the subnetwork related to inflammation, derived from the expression data mapping are AKT1, IL6, and TLR4. After conducting molecular docking studies of anti-inflammatory drugs with these targets, Resveratrol and Fentanyl were identified as potential drugs with anti-inflammatory effects and suitable for epilepsy. Thus, we suggest further experimental studies for validation of using anti-inflammatory drugs Resveratrol and Fentanyl against epilepsy.

Keywords

• Proteome
• Transcriptome
• Protein-protein interaction
• Subnetwork analysis
• Molecular docking

References

1. Acungil Z, Özşahin Delibaş EA. (2022). Resveratrol, Oxinflammation and Epilepsy. J TOGU Heal Sci., 2(1), 72-87.
2. Akdağ G, Algın D, Erdinç O. EPİLEPSİ / EPILEPSY. Osmangazi Tıp Dergisi. 2016;38(1).
3. Alcaraz, N., Friedrich, T., Kötzing, T., Krohmer, A., Müller, J., Pauling, J., & Baumbach, J. (2012). Efficient key pathway mining: combining networks and OMICS data. Integrative biology: quantitative biosciences from nano to macro, 4(7), 756–764. https://doi.org/10.1039/c2ib00133k
4. Alcaraz, N., List, M., Dissing-Hansen, M., Rehmsmeier, M., Tan, Q., Mollenhauer, J., Ditzel, H. J., & Baumbach, J. (2016). Robust de novo pathway enrichment with KeyPathwayMiner 5. F1000Research, 5, 1531. https://doi.org/10.12688/f1000research.9054.1
5. Barrett, T., Wilhite, S. E., Ledoux, P., Evangelista, C., Kim, I. F., Tomashevsky, M., Marshall, K. A., Phillippy, K. H., Sherman, P. M., Holko, M., Yefanov, A., Lee, H., Zhang, N., Robertson, C. L., Serova, N., Davis, S., & Soboleva, A. (2013). NCBI GEO: archive for functional genomics data sets--update. Nucleic acids research, 41(Database issue), D991–D995. https://doi.org/10.1093/nar/gks1193
6. Beghi E. (2020). The Epidemiology of Epilepsy. Neuroepidemiology, 54(2), 185–191. https://doi.org/10.1159/000503831
7. Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., & Bourne, P. E. (2000). The Protein Data Bank. Nucleic acids research, 28(1), 235–242. https://doi.org/10.1093/nar/28.1.235
8. Bittigau, P., Sifringer, M., & Ikonomidou, C. (2003). Antiepileptic drugs and apoptosis in the developing brain. Annals of the New York Academy of Sciences, 993, 103–124. https://doi.org/10.1111/j.1749-6632.2003.tb07517.x

9. Cheema, Y., Linton, K. J., & Jabeen, I. (2024). Molecular Modeling Studies to Probe the Binding Hypothesis of Novel Lead Compounds against Multidrug Resistance Protein ABCB1. Biomolecules, 14(1), 114. https://doi.org/10.3390/biom14010114
10. Chouchi, M., Klaa, H., Ben-Youssef Turki, I., & Hila, L. (2019). ABCB1 Polymorphisms and Drug-Resistant Epilepsy in a Tunisian Population. Disease markers, 2019, 1343650. https://doi.org/10.1155/2019/1343650
11. Di Sapia, R., Zimmer, T. S., Kebede, V., Balosso, S., Ravizza, T., Sorrentino, D., Castillo, M. A. M., Porcu, L., Cattani, F., Ruocco, A., Aronica, E., Allegretti, M., Brandolini, L., & Vezzani, A. (2021). CXCL1-CXCR1/2 signaling is induced in human temporal lobe epilepsy and contributes to seizures in a murine model of acquired epilepsy. Neurobiology of disease, 158, 105468. https://doi.org/10.1016/j.nbd.2021.105468
12. Freshour, S. L., Kiwala, S., Cotto, K. C., Coffman, A. C., McMichael, J. F., Song, J. J., Griffith, M., Griffith, O. L., & Wagner, A. H. (2021). Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts. Nucleic acids research, 49(D1), D1144–D1151. https://doi.org/10.1093/nar/gkaa1084
13. Gao, Y. D., & Huang, J. F. (2011). An extension strategy of Discovery Studio 2.0 for non-bonded interaction energy automatic calculation at the residue level. Zoological research, 32(3), 262–266. https://doi.org/10.3724/SP.J.1141.2011.03262
14. Gastaut H. (1970). Clinical and electroencephalographical classification of epileptic seizures. Epilepsia, 11(1), 102–113. https://doi.org/10.1111/j.1528-1157.1970.tb03871.x
15. Guelfi, S., Botia, J. A., Thom, M., Ramasamy, A., Perona, M., Stanyer, L., Martinian, L., Trabzuni, D., Smith, C., Walker, R., Ryten, M., Reimers, M., Weale, M. E., Hardy, J., & Matarin, M. (2019). Transcriptomic and genetic analyses reveal potential causal drivers for intractable partial epilepsy. Brain : a journal of neurology, 142(6), 1616–1630. https://doi.org/10.1093/brain/awz074
16. Hannoodee, S., & Nasuruddin, D. N. (2024). Acute Inflammatory Response. In StatPearls. StatPearls Publishing. PMID: 32310543.
17. Heinzen, E. L., Radtke, R. A., Urban, T. J., Cavalleri, G. L., Depondt, C., Need, A. C., Walley, N. M., Nicoletti, P., Ge, D., Catarino, C. B., Duncan, J. S., Kasperaviciūte, D., Tate, S. K., Caboclo, L. O., Sander, J. W., Clayton, L., Linney, K. N., Shianna, K. V., Gumbs, C. E., Smith, J., … Goldstein, D. B. (2010). Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes. American journal of human genetics, 86(5), 707–718. https://doi.org/10.1016/j.ajhg.2010.03.018
18. Hollander, M., Do, T., Will, T., & Helms, V. (2021). Detecting Rewiring Events in Protein-Protein Interaction Networks Based on Transcriptomic Data. Frontiers in bioinformatics, 1, 724297. https://doi.org/10.3389/fbinf.2021.724297
19. Kushwah RBS. Exploring withanolide a as a potential therapeutic agent against oral cancer: insights from molecular docking and dft calculations. IJBTCM. 2024; Volume 3 (Issue 2): Page 38-45. Lankhuijzen, L. M., & Ridler, T. (2024). Opioids, microglia, and temporal lobe epilepsy. Frontiers in neurology, 14, 1298489. https://doi.org/10.3389/fneur.2023.1298489
20. Laskowski, R. A., Jabłońska, J., Pravda, L., Vařeková, R. S., & Thornton, J. M. (2018). PDBsum: Structural summaries of PDB entries. Protein science : a publication of the Protein Society, 27(1), 129–134. https://doi.org/10.1002/pro.3289
21. Li, Z., You, Z., Li, M., Pang, L., Cheng, J., & Wang, L. (2017). Protective Effect of Resveratrol on the Brain in a Rat Model of Epilepsy. Neuroscience bulletin, 33(3), 273–280. https://doi.org/10.1007/s12264-017-0097-2
22. Liu JYW, Kasperavičiūtė D, Martinian L, Thom M, Sisodiya SM (2012) Neuropathology of 16p13.11 Deletion in Epilepsy. PLoS ONE 7(4): e34813. https://doi.org/10.1371/journal.pone.0034813
23. Maden, S. F., & Acuner, S. E. (2021). Mapping Transcriptome Data to Protein-Protein Interaction Networks of Inflammatory Bowel Diseases Reveals Disease-Specific Subnetworks. Frontiers in genetics, 12, 688447. https://doi.org/10.3389/fgene.2021.
24. Medina-Ceja, L., Salazar-Sánchez, J. C., Ortega-Ibarra, J., & Morales-Villagrán, A. (2019). Connexins-Based Hemichannels/Channels and Their Relationship with Inflammation, Seizures and Epilepsy. International journal of molecular sciences, 20(23), 5976. https://doi.org/10.3390/ijms20235976
25. Mercado-Gómez, O. F., Córdova-Dávalos, L., García-Betanzo, D., Rocha, L., Alonso-Vanegas, M. A., Cienfuegos, J., & Guevara-Guzmán, R. (2018). Overexpression of inflammatory-related and nitric oxide synthase genes in olfactory bulbs from frontal lobe epilepsy patients. Epilepsy research, 148, 37–43. https://doi.org/10.1016/j.eplepsyres.2018.09.012
26. Mora Lagares, L., Minovski, N., Caballero Alfonso, A. Y., Benfenati, E., Wellens, S., Culot, M., Gosselet, F., & Novič, M. (2020). Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies. International journal of molecular sciences, 21(11), 4058. https://doi.org/10.3390/ijms21114058
27. Nada, H., Sivaraman, A., Lu, Q., Min, K., Kim, S., Goo, J. I., Choi, Y., & Lee, K. (2023). Perspective for Discovery of Small Molecule IL-6 Inhibitors through Study of Structure-Activity Relationships and Molecular Docking. Journal of medicinal chemistry, 66(7), 4417–4433. https://doi.org/10.1021/acs.jmedchem.2c01957
28. Pei, Z., Lang, B., Fragoso, Y. D., Shearer, K. D., Zhao, L., Mccaffery, P. J., Shen, S., Ding, Y. Q., McCaig, C. D., & Collinson, J. M. (2014). The expression and roles of Nde1 and Ndel1 in the adult mammalian central nervous system. Neuroscience, 271(100), 119–136. https://doi.org/10.1016/j.neuroscience.2014.04.031
29. Pfisterer, U., Petukhov, V., Demharter, S. et al. Identification of epilepsy-associated neuronal subtypes and gene expression underlying epileptogenesis. Nat Commun 11, 5038 (2020). https://doi.org/10.1038/s41467-020-18752-7
30. Ramos-Matos CF, Bistas KG, Lopez-Ojeda W. (2023). Fentanyl. National Library of Medicine. Treasure Island (FL): StatPearls Publishing. PMID: 29083586. https://www.ncbi.nlm.nih.gov/books/NBK459275/
31. Rana, A., & Musto, A. E. (2018). The role of inflammation in the development of epilepsy. Journal of neuroinflammation, 15(1), 144. https://doi.org/10.1186/s12974-018-1192-7
32. Rawat, C., Kutum, R., Kukal, S., Srivastava, A., Dahiya, U. R., Kushwaha, S., Sharma, S., Dash, D., Saso, L., Srivastava, A. K., & Kukreti, R. (2020). Downregulation of peripheral PTGS2/COX-2 in response to valproate treatment in patients with epilepsy. Scientific reports, 10(1), 2546. https://doi.org/10.1038/s41598-020-59259-x
33. Rönnstrand L. (2004). Signal transduction via the stem cell factor receptor/c-Kit. Cellular and molecular life sciences: CMLS, 61(19-20), 2535–2548. https://doi.org/10.1007/s00018-004-4189-6
34. Scheffer, I. E., Berkovic, S., Capovilla, G., Connolly, M. B., French, J., Guilhoto, L., Hirsch, E., Jain, S., Mathern, G. W., Moshé, S. L., Nordli, D. R., Perucca, E., Tomson, T., Wiebe, S., Zhang, Y. H., & Zuberi, S. M. (2017). ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia, 58(4), 512–521. https://doi.org/10.1111/epi.13709
35. Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003). Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome research, 13(11), 2498–2504. https://doi.org/10.1101/gr.1239303
36. Shetty A. K. (2011). Promise of resveratrol for easing status epilepticus and epilepsy. Pharmacology & therapeutics, 131(3), 269–286. https://doi.org/10.1016/j.pharmthera.2011.04.008
37. Shi, Y., Wei, Z., Feng, Y. et al. Disorders of organic acid metabolism and epilepsy. Acta Epileptologica 6, 24 (2024). https://doi.org/10.1186/s42494-024-00167-2
38. Shorvon S. D. (2011). The etiologic classification of epilepsy. Epilepsia, 52(6), 1052–1057. https://doi.org/10.1111/j.1528-1167.2011.03041.x
39. Steinkellner, H., Madritsch, S., Kluge, M., Seipel, T., Sarne, V., Huber, A., Schosserer, M., Oberle, R., Neuhaus, W., Beribisky, A. V., & Laccone, F. (2024). RNA Sequencing and Weighted Gene Co-Expression Network Analysis Highlight DNA Replication and Key Genes in Nucleolin-Depleted Hepatoblastoma Cells. Genes, 15(12), 1514. https://doi.org/10.3390/genes15121514
40. Szklarczyk, D., Kirsch, R., Koutrouli, M., Nastou, K., Mehryary, F., Hachilif, R., Gable, A. L., Fang, T., Doncheva, N. T., Pyysalo, S., Bork, P., Jensen, L. J., & von Mering, C. (2023). The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic acids research, 51(D1), D638–D646. https://doi.org/10.1093/nar/gkac1000
41. Tran, Q. H., Cao, H. N., Nguyen, D. N., Tran, T. T. N., Le, M. T., Nguyen, Q. T., … Thai, K. M. (2023). Targeting Olokizumab-Interleukin 6 interaction interface to discover novel IL-6 inhibitors. Journal of Biomolecular Structure and Dynamics, 41(23), 14003–14015. https://doi.org/10.1080/07391102.2023.2193990
42. Thiese, M. S., Ronna, B., & Ott, U. (2016). P value interpretations and considerations. Journal of thoracic disease, 8(9), E928–E931. https://doi.org/10.21037/jtd.2016.08.16
43. Trott, O., & Olson, A. J. (2010). AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of computational chemistry, 31(2), 455–461. https://doi.org/10.1002/jcc.21334
44. Uddin, J., Garcia, H. H., Gilman, R. H., Gonzalez, A. E., & Friedland, J. S. (2005). Monocyte-astrocyte networks and the regulation of chemokine secretion in neurocysticercosis. Journal of immunology (Baltimore, Md.: 1950), 175(5), 3273–3281. https://doi.org/10.4049/jimmunol.175.5.3273
45. Uzuner, D., Akkoç, Y., Peker, N. et al. Transcriptional landscape of cellular networks reveal interactions driving the dormancy mechanisms in cancer. Sci Rep 11, 15806 (2021). https://doi.org/10.1038/s41598-021-94005-x
46. Vezzani, A., French, J., Bartfai, T., & Baram, T. Z. (2011). The role of inflammation in epilepsy. Nature reviews. Neurology, 7(1), 31–40. https://doi.org/10.1038/nrneurol.2010.178
47. Vezzani, A., Fujinami, R. S., White, H. S., Preux, P. M., Blümcke, I., Sander, J. W., & Löscher, W. (2016). Infections, inflammation and epilepsy. Acta neuropathologica, 131(2), 211–234. https://doi.org/10.1007/s00401-015-1481-5
48. Wang, Y., Wang, Q., Huang, H., Huang, W., Chen, Y., McGarvey, P. B., Wu, C. H., Arighi, C. N., & UniProt Consortium (2021). A crowdsourcing open platform for literature curation in UniProt. PLoS biology, 19(12), e3001464. https://doi.org/10.1371/journal.pbio.3001464
49. Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., Assempour, N., Iynkkaran, I., Liu, Y., Maciejewski, A., Gale, N., Wilson, A., Chin, L., Cummings, R., Le, D., Pon, A., … Wilson, M. (2018). DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic acids research, 46(D1), D1074–D1082. https://doi.org/10.1093/nar/gkx1037
50. Yu, J. Y., & Pearl, P. L. (2013). Metabolic causes of epileptic encephalopathy. Epilepsy research and treatment, 2013, 124934. https://doi.org/10.1155/2013/124934
51. Zhu, Y., Huang, D., Zhao, Z., & Lu, C. (2021). Bioinformatic analysis identifies potential key genes of epilepsy. PloS one, 16(9), e0254326. https://doi.org/10.1371/journal.pone.0254326n
52. Zhuang, W., Ye, T., Wang, W., Song, W., & Tan, T. (2023). CTNNB1 in neurodevelopmental disorders. Frontiers in psychiatry, 14, 1143328. https://doi.org/10.3389/fpsyt.2023.1143328